We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This national report provides insights into the care experienced by cancer patients across England who were treated as day cases or inpatients during the first three months of 2010.
Information to support your recovery after COVID-19.
Official information British people moving to and living in Canada need to know, including residency, healthcare and driving.
High quality care is critical to improving cancer outcomes. While this country has many of the elements required to collect, analyse and publish information; there are also deficiencies in cancer intelligence.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
This document explains the Prostate Cancer Risk Management Programme (PCRMP), PSA testing and evidence against a national screening programme.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Statement by Deputy Foreign Secretary Andrew Mitchell at the United Nations General Assembly 57th session of the Commission on Population and Development.
Find out about the long-term effects some people can have after having COVID-19.
The review of the safety of isotretinoin has concluded.
The Northern Ireland Cancer Registry (NICR) is located in the Centre for Public Health, Queen’s University Belfast and is funded by the Public Health Agency for Northern Ireland. The Department of Health (Northern Ireland) established the Northern Ireland Cancer Registry...
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.
How to apply for repayment of import duty and VAT on protective equipment or medical supplies brought into the UK from non-EU countries from 30 January 2020 up to 31 December 2020.
The Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM) assesses and advises on mutagenic risks to humans. COM is an advisory non-departmental public body, sponsored by the Department of Health and Social Care and the...
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Canada and UK Trade Continuity Agreement enters into force
How investigators and sponsors should manage clinical trials during COVID-19
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.